BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 26754406)

  • 1. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
    Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
    Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
    Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
    Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new facts about hyperthermia-induced modulations of the immune system.
    Frey B; Weiss EM; Rubner Y; Wunderlich R; Ott OJ; Sauer R; Fietkau R; Gaipl US
    Int J Hyperthermia; 2012; 28(6):528-42. PubMed ID: 22690925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia.
    Finkel P; Frey B; Mayer F; Bösl K; Werthmöller N; Mackensen A; Gaipl US; Ullrich E
    Oncoimmunology; 2016 Jun; 5(6):e1101206. PubMed ID: 27471606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
    Teitz-Tennenbaum S; Li Q; Rynkiewicz S; Ito F; Davis MA; McGinn CJ; Chang AE
    Cancer Res; 2003 Dec; 63(23):8466-75. PubMed ID: 14679011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
    Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
    Int J Cancer; 2005 Sep; 116(4):624-33. PubMed ID: 15825167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells.
    Brusa D; Migliore E; Garetto S; Simone M; Matera L
    Prostate; 2009 Sep; 69(12):1343-52. PubMed ID: 19496055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
    Buhtoiarov IN; Sondel PM; Eickhoff JC; Rakhmilevich AL
    Immunology; 2007 Mar; 120(3):412-23. PubMed ID: 17163960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages.
    Schildkopf P; Frey B; Ott OJ; Rubner Y; Multhoff G; Sauer R; Fietkau R; Gaipl US
    Radiother Oncol; 2011 Oct; 101(1):109-15. PubMed ID: 21704416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-tumor effect of cisplatin combined with DC vaccine on tumor-bearing mice].
    You HY; Lian WG; Zhang HL; Wang JX; Zhang KX; Song SX
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):336-40. PubMed ID: 22883452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential.
    Masunaga S; Liu Y; Sakurai Y; Tanaka H; Suzuki M; Kondo N; Maruhashi A; Ono K
    Int J Hyperthermia; 2012; 28(7):636-44. PubMed ID: 22946564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia.
    Nakayama J; Urabe A; Terao H; Taniguchi S; Hori Y
    Pigment Cell Res; 1993 Mar; 6(2):111-6. PubMed ID: 8100634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma.
    Wang XY; Arnouk H; Chen X; Kazim L; Repasky EA; Subjeck JR
    J Immunol; 2006 Aug; 177(3):1543-51. PubMed ID: 16849461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of B16 melanoma cell lines, F1 and F10, to hyperthermia, lymphokine-activated killer cells and a combination of both in vitro.
    Nakayama J; Moroi Y; Toshitani A; Taniguchi S; Okamoto-Inoue M; Hori Y
    Br J Dermatol; 1992 Feb; 126(2):131-6. PubMed ID: 1536778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined therapeutic modality with hyperthermia and locally administered rIFN-beta inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates.
    Nakayama J; Toyofuku K; Urabe A; Taniguchi S; Hori Y
    J Dermatol Sci; 1993 Dec; 6(3):240-6. PubMed ID: 8136321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of B16 melanoma.
    Umeshappa CS; Zhu Y; Bhanumathy KK; Omabe M; Chibbar R; Xiang J
    Cancer Biother Radiopharm; 2015 Mar; 30(2):72-8. PubMed ID: 25714591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.